JPS5998082A - 1,2―ジフェニル―4―〔2―(フェニルスルフィニル)エチル〕―4―(ニコチノイルオキシメチル)―ピラゾリジン―3,5―ジオン、その製造法およびそれを有効成分とする血栓治療剤 - Google Patents
1,2―ジフェニル―4―〔2―(フェニルスルフィニル)エチル〕―4―(ニコチノイルオキシメチル)―ピラゾリジン―3,5―ジオン、その製造法およびそれを有効成分とする血栓治療剤Info
- Publication number
- JPS5998082A JPS5998082A JP58193326A JP19332683A JPS5998082A JP S5998082 A JPS5998082 A JP S5998082A JP 58193326 A JP58193326 A JP 58193326A JP 19332683 A JP19332683 A JP 19332683A JP S5998082 A JPS5998082 A JP S5998082A
- Authority
- JP
- Japan
- Prior art keywords
- phenylsulfinyl
- formula
- dione
- ethyl
- pyrazolidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/28—Two oxygen or sulfur atoms
- C07D231/30—Two oxygen or sulfur atoms attached in positions 3 and 5
- C07D231/32—Oxygen atoms
- C07D231/36—Oxygen atoms with hydrocarbon radicals, substituted by hetero atoms, attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT23770A/82 | 1982-10-15 | ||
| IT23770/82A IT1191034B (it) | 1982-10-15 | 1982-10-15 | Composto ad attivita' vasodilatatrice,antiaggregante e ipocolesterolemizzante,procedimento per la sua preparazione e composizione farmaceutiche relative |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5998082A true JPS5998082A (ja) | 1984-06-06 |
| JPS6346076B2 JPS6346076B2 (enExample) | 1988-09-13 |
Family
ID=11209829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58193326A Granted JPS5998082A (ja) | 1982-10-15 | 1983-10-14 | 1,2―ジフェニル―4―〔2―(フェニルスルフィニル)エチル〕―4―(ニコチノイルオキシメチル)―ピラゾリジン―3,5―ジオン、その製造法およびそれを有効成分とする血栓治療剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4542141A (enExample) |
| EP (1) | EP0106251B1 (enExample) |
| JP (1) | JPS5998082A (enExample) |
| AT (1) | ATE24906T1 (enExample) |
| DE (1) | DE3369136D1 (enExample) |
| ES (1) | ES526461A0 (enExample) |
| IT (1) | IT1191034B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5525727A (en) * | 1982-05-18 | 1996-06-11 | University Of Florida | Brain-specific drug delivery |
| US4824850A (en) * | 1982-05-18 | 1989-04-25 | University Of Florida | Brain-specific drug delivery |
| US5008257A (en) * | 1982-05-18 | 1991-04-16 | University Of Florida | Brain-specific drug delivery |
| US5187158A (en) * | 1982-05-18 | 1993-02-16 | University Of Florida | Brain-specific drug delivery |
| BR9205752A (pt) * | 1991-03-19 | 1994-11-08 | Ciba Geigy Ag | Novos compostos herbicidamente, acaricidamente e inseticidamente ativos |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL89284C (enExample) * | 1954-05-22 | |||
| GB1084247A (enExample) * | 1963-08-20 | |||
| BR6685653D0 (pt) * | 1965-12-23 | 1973-12-27 | Spofa Vereinigte Pharma Werke | Processo para a fabricacao de novas 4-substituidas 1,2-difenil-3,5-dioxopirazolidinas |
| ES347942A1 (es) * | 1967-11-23 | 1969-03-01 | Esteve Labor Dr | Procedimiento para la obtencion de nuevos esteres de acidosp-halogenobenzoicos. |
| AT324331B (de) * | 1972-09-27 | 1975-08-25 | Hurka Wilhelm | Verfahren zur herstellung neuer nicotin- und isonicotinsäureester substituierter pyrazolidine |
| FR2433020A1 (fr) * | 1978-08-09 | 1980-03-07 | Synthelabo | Derives de pyrazolidine-dione et leur application en therapeutique |
-
1982
- 1982-10-15 IT IT23770/82A patent/IT1191034B/it active
-
1983
- 1983-10-02 AT AT83109845T patent/ATE24906T1/de not_active IP Right Cessation
- 1983-10-02 DE DE8383109845T patent/DE3369136D1/de not_active Expired
- 1983-10-02 EP EP83109845A patent/EP0106251B1/en not_active Expired
- 1983-10-07 US US06/539,839 patent/US4542141A/en not_active Expired - Fee Related
- 1983-10-14 ES ES526461A patent/ES526461A0/es active Granted
- 1983-10-14 JP JP58193326A patent/JPS5998082A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| ES8507538A1 (es) | 1985-10-01 |
| IT8223770A1 (it) | 1984-04-15 |
| IT8223770A0 (it) | 1982-10-15 |
| DE3369136D1 (en) | 1987-02-19 |
| JPS6346076B2 (enExample) | 1988-09-13 |
| US4542141A (en) | 1985-09-17 |
| EP0106251B1 (en) | 1987-01-14 |
| ES526461A0 (es) | 1985-10-01 |
| EP0106251A1 (en) | 1984-04-25 |
| ATE24906T1 (de) | 1987-01-15 |
| IT1191034B (it) | 1988-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4146637A (en) | Anti-inflammatory n-acyl substituted benzamides | |
| HU184966B (en) | Process for producing phenyl-piperazine derivatives of anti-agression activity | |
| US3639477A (en) | Novel propoxyguanidine compounds and means of producing the same | |
| KR20040088474A (ko) | 중수소화된 디하이드로푸라논 및 이를 함유한 약물 | |
| JPS5838263A (ja) | ピリダジン誘導体 | |
| CZ20022096A3 (cs) | Kvarterní amoniová sloučenina pro použití při léčení a/nebo prevenci kašle u teplokrevného živočicha a farmaceutický prostředek ji obsahující | |
| JPS5998082A (ja) | 1,2―ジフェニル―4―〔2―(フェニルスルフィニル)エチル〕―4―(ニコチノイルオキシメチル)―ピラゾリジン―3,5―ジオン、その製造法およびそれを有効成分とする血栓治療剤 | |
| US4127671A (en) | P-acetamidophenyl diethylaminoacetate | |
| JPS61158922A (ja) | フイブリンからの不溶性フイブリンの形成阻止剤 | |
| US6809116B2 (en) | Materials and methods for the treatment of depression | |
| SU1053749A3 (ru) | Способ получени 1,2-бис-(никотинамидо)-пропана или его солей с фармацевтически приемлемой кислотой | |
| JPS62123164A (ja) | 新規なアミノアルキル置換尿素誘導体、その酸付加塩および鏡像異性体、それらの製法並びに薬用配合物 | |
| FR2465710A1 (fr) | Nouveaux amino-2 benzoyl-3 phenylacetamides et leurs homologues cycliques utiles comme medicaments et compositions therapeutiques et formes pharmaceutiques les contenant | |
| JPS62155245A (ja) | 新規なパントテニル誘導体 | |
| JPS59152368A (ja) | メルカプト酢酸のアミド及び3―メルカプトプロヒオン酸から誘導される新規薬物 | |
| US4272529A (en) | O-Alcoxycarbonylphenyl esters of anthranilic acid with therapeutical activity, method for their preparation and related pharmaceutical composition | |
| KR880002287B1 (ko) | 아세틸살리실산 글리콜에스테르 화합물 및 그의 제조방법 | |
| EP0069527B1 (en) | Cystine derivatives | |
| JPS6185370A (ja) | 4h‐1,2,4‐トリアゾール誘導体の新製造法、得られる新トリアゾール、それらの薬剤としての使用及びそれらを含む製薬組成物 | |
| JPS6137264B2 (enExample) | ||
| JPH075545B2 (ja) | ピロリジノン化合物及び脳機能障害改善剤 | |
| JPS6118746A (ja) | (+)6‐メトキシ‐α‐メチル‐2‐ナフタレン酢酸エステル,その製法,および医薬組成物 | |
| US4546197A (en) | Pharmaceutical composition and process for the manufacture thereof | |
| EP0424901A1 (en) | Dihydropyridine derivatives and pharmaceutical compositions | |
| US4451468A (en) | Acidiferous 17-normal-pentyl sparteine tartaric and fumaric acid salts pharmaceutical compositions thereof |